Human Papillomavirus Testing and Liquid-Based Cytology: Results at Recruitment From the New Technologies for Cervical Cancer Randomized Controlled Trial
Top Cited Papers
Open Access
- 7 June 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 98 (11) , 765-774
- https://doi.org/10.1093/jnci/djj209
Abstract
Background: Although testing for human papillomavirus (HPV) has higher sensitivity and lower specificity than cytology alone for detecting cervical intraepithelial neoplasia (CIN), studies comparing conventional and liquid-based cytology have had conflicting results. Methods: In the first phase of a two-phase multicenter randomized controlled trial, women aged 35–60 years in the conventional arm ( n = 16 658) were screened using conventional cytology, and women in the experimental arm ( n = 16 706) had liquid-based cytology and were tested for high-risk HPV types using the Hybrid Capture 2 assay. Women in the conventional arm were referred to colposcopy with atypical cells of undetermined significance (ASCUS) or higher and those in the experimental arm were referred with ASCUS or higher cytology or with a positive (≥1 pg/mL) HPV test. Sensitivity and positive predictive value (PPV) for detection of cervical intraepithelial neoplasia grade 2 or higher (CIN2+) were calculated. Results: The screening methods and referral criterion applied in the experimental arm had higher sensitivity than that in the conventional arm (relative sensitivity = 1.47; 95% confidence interval [CI] = 1.03 to 2.09) but a lower PPV (relative PPV = 0.40; 95% CI = 0.23 to 0.66). With HPV testing alone at ≥1 pg/mL and at ≥2 pg/mL, the gain in sensitivity compared with the conventional arm remained similar (relative sensitivity = 1.43, 95% CI = 1.00 to 2.04 and relative sensitivity = 1.41, 95% CI = 0.98 to 2.01, respectively) but PPV progressively improved (relative PPV = 0.58, 95% CI = 0.33 to 0.98 and relative PPV = 0.75, 95% CI = 0.45 and 1.27, respectively). Referral based on liquid-based cytology alone did not increase sensitivity compared with conventional cytology (relative sensitivity = 1.06; 95% CI = 0.72 to 1.55) but reduced PPV (relative PPV = 0.57; 95% CI = 0.39 to 0.82). Conclusions: HPV testing alone was more sensitive than conventional cytology among women 35–60 years old. Adding liquid-based cytology improved sensitivity only marginally but increased false-positives. HPV testing using Hybrid Capture 2 with a 2 pg/mL cutoff may be more appropriate than a 1 pg/mL cutoff for primary cervical cancer screening.Keywords
This publication has 34 references indexed in Scilit:
- Management of women who test positive for high-risk types of human papillomavirus: the HART studyThe Lancet, 2003
- Evaluation of Human Papillomavirus Testing in Primary Screening for Cervical AbnormalitiesJAMA, 2002
- Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 womenBritish Journal of Cancer, 2001
- Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopyInternational Journal of Cancer, 2000
- Evaluation of alternative methods of cervical cancer screening for resource-poor settingsCancer, 2000
- Human Papillomavirus DNA Testing for Cervical Cancer Screening in Low-Resource SettingsJNCI Journal of the National Cancer Institute, 2000
- HPV DNA Testing in Cervical Cancer ScreeningJAMA, 2000
- HPV testing in primary screening of older womenBritish Journal of Cancer, 1999
- Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 womenBritish Journal of Cancer, 1999
- Human papillomavirus testing in primary cervical screeningThe Lancet, 1995